BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10980196)

  • 21. Salt dependency of chromaffin granule aggregation by annexin II tetramer.
    Jones PG; Fitzpatrick S; Waisman DM
    Biochemistry; 1994 Nov; 33(46):13751-60. PubMed ID: 7947786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites.
    Thiel C; Osborn M; Gerke V
    J Cell Sci; 1992 Nov; 103 ( Pt 3)():733-42. PubMed ID: 1478969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterization of a dimeric complex between the short cytoplasmic domain of CEACAM1 and the pseudo tetramer of S100A10-Annexin A2 using NMR and molecular dynamics.
    Hu W; Bhattacharya S; Hong T; Wong P; Li L; Vaidehi N; Kalkum M; Shively JE
    Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183451. PubMed ID: 32835655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of individual domains of annexin I in its vesicle binding and vesicle aggregation: a comprehensive mutagenesis study.
    Bitto E; Cho W
    Biochemistry; 1998 Jul; 37(28):10231-7. PubMed ID: 9665730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The conserved core domains of annexins A1, A2, A5, and B12 can be divided into two groups with different Ca2+-dependent membrane-binding properties.
    Patel DR; Isas JM; Ladokhin AS; Jao CC; Kim YE; Kirsch T; Langen R; Haigler HT
    Biochemistry; 2005 Mar; 44(8):2833-44. PubMed ID: 15723527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration.
    Dubois T; Mira JP; Feliers D; Solito E; Russo-Marie F; Oudinet JP
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1277-82. PubMed ID: 9494097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer.
    Choi KS; Fitzpatrick SL; Filipenko NR; Fogg DK; Kassam G; Magliocco AM; Waisman DM
    J Biol Chem; 2001 Jul; 276(27):25212-21. PubMed ID: 11319229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ca2+-dependent and phospholipid-independent binding of annexin 2 and annexin 5.
    Brooks ND; Grundy JE; Lavigne N; Derry MC; Restall CM; MacKenzie CR; Waisman DM; Pryzdial EL
    Biochem J; 2002 Nov; 367(Pt 3):895-900. PubMed ID: 12139487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion of lamellar body with plasma membrane is driven by the dual action of annexin II tetramer and arachidonic acid.
    Chattopadhyay S; Sun P; Wang P; Abonyo B; Cross NL; Liu L
    J Biol Chem; 2003 Oct; 278(41):39675-83. PubMed ID: 12902340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of three unique Ca(2+)-binding sites in human annexin II.
    Jost M; Thiel C; Weber K; Gerke V
    Eur J Biochem; 1992 Aug; 207(3):923-30. PubMed ID: 1386804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reorganization of cytoskeleton during surfactant secretion in lung type II cells: a role of annexin II.
    Singh TK; Abonyo B; Narasaraju TA; Liu L
    Cell Signal; 2004 Jan; 16(1):63-70. PubMed ID: 14607276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
    Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
    J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
    Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
    Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol enhances phospholipid binding and aggregation of annexins by their core domain.
    Ayala-Sanmartin J
    Biochem Biophys Res Commun; 2001 Apr; 283(1):72-9. PubMed ID: 11322769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a Ca(2+)-binding site in human annexin II by site-directed mutagenesis.
    Thiel C; Weber K; Gerke V
    J Biol Chem; 1991 Aug; 266(22):14732-9. PubMed ID: 1830590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium and membrane-binding properties of monomeric and multimeric annexin II.
    Evans TC; Nelsestuen GL
    Biochemistry; 1994 Nov; 33(45):13231-8. PubMed ID: 7947730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of carbohydrate-binding protein p33/41: relation with annexin IV, molecular basis of the doublet forms (p33 and p41), and modulation of the carbohydrate binding activity by phospholipids.
    Kojima K; Yamamoto K; Irimura T; Osawa T; Ogawa H; Matsumoto I
    J Biol Chem; 1996 Mar; 271(13):7679-85. PubMed ID: 8631806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ca
    Lindsay S; Bartolotti L; Li Y
    Proteins; 2023 Aug; 91(8):1042-1053. PubMed ID: 36965169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in the N-terminal domain conformation of annexin I that correlates with liposome aggregation is impaired by Ser-27 to Glu mutation that mimics phosphorylation.
    Porte F; de Santa Barbara P; Phalipou S; Liautard JP; Widada JS
    Biochim Biophys Acta; 1996 Apr; 1293(2):177-84. PubMed ID: 8620027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of annexin II tetramer in plasminogen activation.
    Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
    Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.